Trial Outcomes & Findings for High Intensity Interval Training in Endometrial Cancer (NCT NCT04025229)
NCT ID: NCT04025229
Last Updated: 2025-10-15
Results Overview
Change in Ki-67 proliferation values within the HIIT intervention group between the initial biopsy and the surgical biopsy. The percentage of tumor cells that are positive for Ki-67, indicating they are in the active phases of the cell cycle (not resting). Low Ki-67 (\<10-15%): Slower-growing tumor. Intermediate (15-30%): Moderately proliferative. High (\>30%): Fast-growing, potentially more aggressive.
COMPLETED
NA
30 participants
3 years
2025-10-15
Participant Flow
Participants enrolled were enrolled at a single North Carolina site between 09/23/2019 and 09/08/2022.
Thirty participants consented and began the study.
Participant milestones
| Measure |
Control Arm
No HIIT exercise prior to surgery
|
HIIT Exercise
Participants will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery.
HIIT exercise: High-intensity interval training (4 to 6 sessions) prior to surgery.
|
|---|---|---|
|
Overall Study
STARTED
|
10
|
20
|
|
Overall Study
COMPLETED
|
9
|
16
|
|
Overall Study
NOT COMPLETED
|
1
|
4
|
Reasons for withdrawal
| Measure |
Control Arm
No HIIT exercise prior to surgery
|
HIIT Exercise
Participants will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery.
HIIT exercise: High-intensity interval training (4 to 6 sessions) prior to surgery.
|
|---|---|---|
|
Overall Study
Adverse Event
|
1
|
0
|
|
Overall Study
Withdrawal by Subject
|
0
|
2
|
|
Overall Study
Death
|
0
|
1
|
|
Overall Study
Physician Decision
|
0
|
1
|
Baseline Characteristics
High Intensity Interval Training in Endometrial Cancer
Baseline characteristics by cohort
| Measure |
Control Arm
n=9 Participants
No HIIT exercise prior to surgery.
|
HIIT Exercise
n=16 Participants
Participants will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery.
HIIT exercise: High-intensity interval training (4 to 6 sessions) prior to surgery
|
Total
n=25 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
58.9 years
STANDARD_DEVIATION 5.3 • n=5 Participants
|
54.9 years
STANDARD_DEVIATION 8.2 • n=7 Participants
|
56.4 years
STANDARD_DEVIATION 7.4 • n=5 Participants
|
|
Sex: Female, Male
Female
|
9 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
25 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
9 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
24 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
8 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
9 participants
n=5 Participants
|
16 participants
n=7 Participants
|
25 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 3 yearsPopulation: Participants who started the study and provided a sample were included.
Change in Ki-67 proliferation values within the HIIT intervention group between the initial biopsy and the surgical biopsy. The percentage of tumor cells that are positive for Ki-67, indicating they are in the active phases of the cell cycle (not resting). Low Ki-67 (\<10-15%): Slower-growing tumor. Intermediate (15-30%): Moderately proliferative. High (\>30%): Fast-growing, potentially more aggressive.
Outcome measures
| Measure |
Control Arm- Baseline
n=8 Participants
The sample provided by participants who will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery at baseline.
|
Control Arm -At Surgery
n=8 Participants
The sample provided by participants who will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery at surgery.
|
HIIT- Baseline
n=16 Participants
The sample provided by participants who will perform HIIT exercises as instructed by the study team at baseline.
|
HIIT -At Surgery
n=16 Participants
The sample provided by participants who will perform HIIT exercises as instructed by the study team during surgery.
|
|---|---|---|---|---|
|
Change in Proliferative Markers in Endometrium Before and After HIIT Exercises
|
21.7 Percentage of cells expressing Ki67
Standard Deviation 12.2
|
15.1 Percentage of cells expressing Ki67
Standard Deviation 14.4
|
21.7 Percentage of cells expressing Ki67
Standard Deviation 12.2
|
20.2 Percentage of cells expressing Ki67
Standard Deviation 15.7
|
Adverse Events
HIIT Exercise
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Luz Andrea Cuaboy
UNC Lineberger Comprehensive Cancer Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place